STAT

AUGUST 28, 2024

MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to hear. Take our money, the company said, and together we can bring about a future where primary care leads. A future where doctors can take better care of their patients, and reap the financial rewards of improved health. We’ll handle the business side while you look after your patients.

145

145

Pharmacy Times

AUGUST 28, 2024

Mirdametinib is an oral, allosteric small molecule MEK inhibitor to treat pediatric patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

FDA 123

FDA 123

STAT

AUGUST 28, 2024

Fatal drug overdoses shot up during the peak of Covid-19 in 2020. And as the dust settled on the pandemic, it quickly became clear that one demographic group had fared far worse than any other: Native Americans.  Now, to combat the drug crisis and its disproportionate impact on indigenous people, the federal government is launching an initiative specifically meant to bolster research into addiction and overdose within native communities.

135

135

PharmaVoice

AUGUST 28, 2024

By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.

FDA 134

FDA 134

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

AUGUST 28, 2024

Neurocrine Biosciences said Wednesday that the lowest dose of an experimental pill for schizophrenia reduced psychosis reported by patients in a mid-stage study, but higher doses of the drug also tested were ineffective.  The company said the study results supported advancing the medicine into Phase 3 studies next year. Investors viewed the mixed data with more concern, sending Neurocrine’s stock down 18% in early trading.

130

130

Pharmacy Times

AUGUST 28, 2024

In survivors of lymphoma with fragmented transition of care, preparedness and activation for the next phase of their survivorship was lacking.

132

132

Fierce Pharma

AUGUST 28, 2024

The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech. | The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech.

123

123

Pharmacy Times

AUGUST 28, 2024

Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

142

142

Fierce Pharma

AUGUST 28, 2024

Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. | Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs.

115

115

Pharmacy Times

AUGUST 28, 2024

Previously, the device was indicated for the management of type 1 diabetes in patients aged 2 years and older.

FDA 134

FDA 134

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 28, 2024

The £400m pledged by industry as part of the new VPAG voluntary scheme of pharma rebates will be used mainly to support the UK clinical research sector

116

116

Drug Topics

AUGUST 28, 2024

Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.

112

112

The Guardian - Pharmaceutical Industry

AUGUST 28, 2024

There must be transparency over funding to medics from the pharmaceutical industry – and that’s only the start Shouldn’t we be able to trust doctors to give us independent advice? Earlier this year, there was an outcry when it appeared that a doctor who often appeared on TV to speak about Covid vaccines had been paid a significant sum by the pharmaceutical company AstraZeneca.

Vaccines 109

Vaccines Pharmaceutical Companies Pharmaceutical Companies 109

Pharmacy Times

AUGUST 28, 2024

Community pharmacists can participate in continuing education epilepsy programs, but they are usually not specific to pharmacy practice.

111

111

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

AUGUST 28, 2024

Three years after launching Leqvio in the U.S., Novartis is still steadily advancing its blockbuster ambitions for the cholesterol-lowering drug. | After a positive phase 3 readout, Novartis said it aims to apply cholesterol-lowering Leqvio across the "full spectrum" of atherosclerotic cardiovascular disease.

102

102

Pharmacy Times

AUGUST 28, 2024

Accurate, effective screening is crucial for connecting patients with needed financial resources and support.

125

125

Fierce Pharma

AUGUST 28, 2024

Delaware's Supreme Court has upheld a GSK appeal, deciding to review the state’s Superior Court decision to allow expert testimony in Zantac lawsuits.

105

105

Pharmacy Times

AUGUST 28, 2024

Pharmacists can play a crucial role in educating patients on the proper storage and administration of evolocumab.

123

123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

AUGUST 28, 2024

A virtual voice assistant used to contact patients after heart procedures can make early discharge possible and spot complications

113

113

Fierce Pharma

AUGUST 28, 2024

As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it ca | As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it can bring to the table.

96

96

Pharmaceutical Commerce

AUGUST 28, 2024

Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain.

104

104

Pharmacy Times

AUGUST 28, 2024

"Risk Less. Do More." plans to partner with national, state, and local organizations to provide resources to families and communities on how to protect themselves from RSV, influenza, and COVID-19.

Vaccines 86

Vaccines 86

pharmaphorum

AUGUST 28, 2024

Changing Faces announces new board of directors appointments from July 2024 for Immatics, Memo Therapeutics, Scancell, Abcuro and more. Stay updated on the latest developments in the biotech industry.

93

93

Drug Topics

AUGUST 28, 2024

Check out this list of our top 10 stories from August 2024.

123

123

The Guardian - Pharmaceutical Industry

AUGUST 28, 2024

Large Korean study suggests sodium-glucose cotransporter-2 inhibitors may prevent dementia A drug used to treat type 2 diabetes is associated with a 35% lower risk of dementia, according to research. The number of people with dementia globally is expected to nearly triple to 153 million by 2050. The health and social costs linked to dementia already exceed $1tn (£780bn) a year , research shows.

91

91

Drug Topics

AUGUST 28, 2024

Additional data will be presented at a scientific meeting later this year.

112

112

STAT

AUGUST 28, 2024

Good morning. As a treat for Labor Day weekend, we’re running a deal for STAT+ subscriptions. If you use the code LABORDAY at checkout, you can get 25% off your first year. Learn more here. Now onto the biotech news of the day.

93

93

Drug Topics

AUGUST 28, 2024

Don’t miss out on the latest pharmacy insights in the Drug Topics July/August issue.

98

98

STAT

AUGUST 28, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

93

93

pharmaphorum

AUGUST 28, 2024

Join the EVERSANA webinar to discover how content transformation is revolutionising pharma marketing strategies. Learn how to shift the paradigm and stay ahead in the industry.

84

84

STAT

AUGUST 28, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Good morning! Amid today’s news, two items on pregnancy that are interesting and eerie to read in tandem. And on top of that, two itchy pieces of mosquito-related news from STAT’s Helen Branswell.

Insurance 83

Insurance 83

pharmaphorum

AUGUST 28, 2024

Novartis builds case for fast-growing cholesterol drug Leqvio, as V-MONO trial shows benefit as a monotherapy in patients at lower risk of heart disease

87

87

Pharmacy Times

AUGUST 28, 2024

Examples include reviewing antibiotic doses, identifying drug-drug interactions, and implementing fall prevention strategies.

73

73